|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: GUILFORD PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
Next: GUILFORD PHARMACEUTICALS INC, S-4/A, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 14,078
<SECURITIES> 115,299
<RECEIVABLES> 952
<ALLOWANCES> 0
<INVENTORY> 1,883
<CURRENT-ASSETS> 112,857
<PP&E> 29,149
<DEPRECIATION> 14,587
<TOTAL-ASSETS> 148,629
<CURRENT-LIABILITIES> 12,360
<BONDS> 6,045
0
0
<COMMON> 237
<OTHER-SE> 129,987
<TOTAL-LIABILITY-AND-EQUITY> 148,629
<SALES> 1,207
<TOTAL-REVENUES> 5,558
<CGS> 657
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 28,435
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 274
<INCOME-PRETAX> (19,680)
<INCOME-TAX> 0
<INCOME-CONTINUING> (19,680)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (19,680)
<EPS-BASIC> (0.84)
<EPS-DILUTED> (0.84)
</TABLE>
|
|